Paper8301033
Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.
Meyer-Wyss B and 3 others. J Hepatol, 1993. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. Papers, record 8301033. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8301033
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lidocaine | Major topic |
| Liver Diseases | Major topic |
| Adolescent | |
| Adult | |
| Aminopyrine | |
| Breath Tests | |
| Child | |
| Galactose | |
| Humans | |
| Liver Function Tests |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18762933 | Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18762933 | PubMed |
| 12587953 | Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis. | Eur J Drug Metab Pharmacokinet | 2002 | https://conductscience.org/library/papers/12587953 | PubMed |
| 12498283 | Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis? | Dig Dis Sci | 2002 | https://conductscience.org/library/papers/12498283 | PubMed |
| 11215745 | Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C. | Dig Dis Sci | 2000 | https://conductscience.org/library/papers/11215745 | PubMed |
| 10219840 | Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration. | Dig Dis Sci | 1999 | https://conductscience.org/library/papers/10219840 | PubMed |
| 9820880 | Effect of hepatic insufficiency on pharmacokinetics and drug dosing. | Pharm World Sci | 1998 | https://conductscience.org/library/papers/9820880 | PubMed |
| 9635625 | Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis. | Dig Dis Sci | 1998 | https://conductscience.org/library/papers/9635625 | PubMed |
| 8582436 | Pharmacokinetics of lidocaine and its major metabolite- monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction. | Eur J Drug Metab Pharmacokinet | 1995 | https://conductscience.org/library/papers/8582436 | PubMed |
| 8582120 | Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/8582120 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8301033
GET https://conductscience.org/api/papers/v1/8301033/authors